NPPES file of Aug 9, 2026

Robert G. Maki, MD, PHD

Hematology & Oncology Physician · Philadelphia, PA

Robert G. Maki, MD, PHD is a hematology & oncology physician with a practice address in Philadelphia, Pennsylvania, and NPI 1538130323, issued on Jan 30, 2006. Check the license (Pennsylvania MD469013, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1538130323
Name
Robert G. Maki
Credential
MD, PHD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License numbers
MD469013 PA
213568 NY
Self-reported in NPPES; status is on the state search
Practice location
3400 Civic Center Blvd, Philadelphia, PA 19104
Phone
(215) 615-1594
Enumerated
Jan 30, 2006
Record last updated
Feb 2, 2021 (not updated in 5 years: call before relying on the address or phone)
Medicare enrollment
Enrolled (PECOS I20100415000539); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 3400 Civic Center Blvd

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Erin Aakhus, M.D.Hematology & Oncology Physician1255652087
  2. Patricia Abbott, PA-CMedical Physician Assistant1316011018
  3. Nawar Abdul Latif, M.D.Gynecologic Oncology Physician1023247335
  4. Srinath Adusumalli, MDCardiovascular Disease Physician1720373418
  5. Shivani AgarwalEndocrinology, Diabetes & Metabolism Physician1104144708
  6. Charu Aggarwal, MD, MPHHematology & Oncology Physician1114181740

Verify Robert G. Maki in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
    Search for license MD469013
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Pennsylvania license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

54% fewer Medicare Part D claims than the average hematology & oncology physician in 2024

401 Medicare Part D claims for 87 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 15% of claims. 31 claims were for opioids.

  1. Robert Maki401
  2. Specialty average877

Most prescribed

  1. Imatinib Mesylate82 claims
  2. Ibrance27 claims
  3. Ondansetron Hcl24 claims
  4. Oxycodone Hcl17 claims
  5. Dexamethasone12 claims
  6. Gabapentin12 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 93.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score86.8
  2. Costnot scored (reweighted)
  3. Promoting interoperabilitynot scored (reweighted)
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $13,529.48

11 payments; by number, the most common kind was food and beverage; the largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Robert Maki$13,529
  2. Specialty average$7,481

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

  1. Memorial Solid Tumor GroupNew York, NY
  2. Msk NassauUniondale, NY

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Robert G. Maki among 784 hematology & oncology physician records in Pennsylvania

Robert G. Maki, MD, PHD is one of 784 hematology & oncology physician records with a practice address in Pennsylvania. 83% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 13% of them.

  • NPI issued2006 · 13% of these records are older, 55% newer
  • In a Medicare fileYes · 83% of these records are
  • In the CMS Doctors and Clinicians fileYes · 71% of these records are
  • Graduated1992 · median 2004 among the 553 with a school on file
  • Record last updated2021 · 60% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Hematology & Oncology Physician providers in Pennsylvania

There are 784 hematology & oncology physician records in Pennsylvania.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. Roger Cohen, MDPhiladelphia, PA 191041639146939
  2. Nevena Damjanov, MDPhiladelphia, PA 191041518954395
  3. Andrew Dancis, MDPhiladelphia, PA 191041316988249
  4. Arthur Feldman, MDPhiladelphia, PA 191041518966357
  5. Patrick Fogarty, MDPhiladelphia, PA 191041528016052
  6. Steven Freedman, M.D./PH.D.Philadelphia, PA 191041417932757
  7. Alison Loren, MDPhiladelphia, PA 191041942241641
  8. Carlos Madamba, MDPhiladelphia, PA 191041811994866

Common questions

What is Robert G. Maki, MD, PHD's NPI number?

Robert G. Maki, MD, PHD's National Provider Identifier (NPI) is 1538130323, issued on Jan 30, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Robert G. Maki, MD, PHD located?

The NPPES record lists a practice address at 3400 Civic Center Blvd, Philadelphia, PA, 19104. Phone: (215) 615-1594. Providers update this record themselves, so call before visiting.

How can I verify Robert G. Maki, MD, PHD's license?

NPPES lists Pennsylvania license number MD469013, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Robert G. Maki, MD, PHD prescribe under Medicare Part D?

In 2024, Robert G. Maki, MD, PHD had 401 Medicare Part D claims for 87 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

What is Robert G. Maki, MD, PHD's MIPS final score?

The 2023 MIPS final score is 93.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.